Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Prefilled Syringes Market $11.5 Billion by 2027

The global market for prefilled syringes estimated to cross $11.5 billion by 2027, expanding at a double-digit CAGR of 11.6% over the forecast period, driven by greater acceptance and rapid uptake as a main drug delivery system for parenteral administration of drugs.

Global Pre-filled Syringes Market

Prefilled syringes (PFS) have emerged as one of the fastest-growing choices for unit dose medication as the pharmaceutical industry seeks new and more convenient drug delivery methods. The many benefits of prefilled syringes are fueling one of the medical device industry’s fastest-growing markets.

Pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self-administer injectable drugs at their home instead of the hospital. 

  • Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials.
    • Pre-filled syringes, with their pre measures dosage, can reduce dosing errors and increase patient compliance.
      • Pre-filled cartridges allow injections to be administered more quickly specially in hospital settings.
        • They can diminish overcrowding in emergency rooms and other treatment areas. 
    • The PFS cartridges assure that patients receive accurate dosages. This is especially advantageous for patients who need to self-inject medication, but have no medical training. 
      • The pre-filled syringes have a high level of accuracy, which makes them safer to use. Healthcare professionals benefit from accurate, pre-measured doses, reduced dosing and medication errors, and reduced risk of microbial contamination.

The global pre-filled syringes market report provides market size ($million 2017 to 2027), market share, growth trends and forecast (CAGR%, 2021 to 2027). 

The global prefilled syringes market segmented by product (glass pre-filled syringes, plastic pre-filled syringes), and geography.

  • Parenteral administration of pharmaceutical products is one of the most popular methods used to produce quick onset of action and also 100% bioavailability. Main problem occurs with the parenteral drug delivery is lack of convenience, affordability, accuracy, sterility, safety etc. Such drawbacks with this delivery system makes it less preferable. Hence, all the disadvantages of these systems can be easily overcome by use of prefilled syringes
    • Prefilled syringes are now used across a wide array of therapeutics sectors outside of the traditional domains of anticoagulants and vaccines. The use of prefilled syringes is expected to accelerate over the coming decades.
    • For the pharmaceutical company, the advantages of prefilled syringes are minimizing drug waste; increasing product life span and enhancing level of market share are some of driving market demand.
    • For healthcare workers, prefilled syringes are recognized as an efficient, reliable and convenient method for drug administration.
      • Furthermore, the ease at which patient can self-administer many types of injectables drugs make prefilled syringes of healthcare treatment out of hospital and into home.
  • The global market has expanded and exploring all options outside of the traditional process. In the past, glass syringes dominated the market, but there has been a movement toward plastic and disposable syringes.
    • The occurrence of glass delamination is a serious concern for parenteral drug products. Over the past several years, there has been a series of product recalls involving glass delamination in parenteral drugs stored in vials which has led to heightened industry and regulatory scrutiny.
      • Biologics, particularly monoclonal antibodies, are frequently packaged at high concentration in prefillable syringes traditionally made of glass. However, some biologics are unstable in glass due to sensitivity to silicone oil, tungsten, glue, or metal ions. Syringes made from the plastic cyclic olefin polymer, Daikyo Crystal Zenith® (CZ), with a Flurotec-laminated piston, have none of these issues. 
        • The pre-filled syringes (PFS) are both the storage and the administration device for parenteral therapies, and they continue to increase in popularity due to their convenience, safety, and accuracy of drug delivery.
          • The pre-filled syringes have also been utilized across a wide range of therapeutic sectors, such as vaccines, blood stimulants, and therapeutic proteins.

The global market for prefilled syringes research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

The global market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for prefilled syringes and included in this report are AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson & Company, Bespak, Consort Medical plc (Recipharm Holdings Ltd.), Gerresheimer AG, Haselmeier AG, Keystone Aniline Corporation, Medtronic plc, Nipro Medical Corporation, Schott AG (Carl-Zeiss-Stiftung), SHL Medical/Group, Stevanato Group, Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., and Ypsomed Holding AG.

  • Product
    • Glass Prefilled Syringes
    • Plastic Prefilled Syringes
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • AptarGroup, Inc.
    • Baxter International, Inc.
    • Becton, Dickinson & Company
    • Bespak
    • Consort Medical plc (Recipharm Holdings Ltd.)
    • Gerresheimer AG
    • Haselmeier AG
    • Keystone Aniline Corporation
    • Medtronic plc
    • Nipro Medical Corporation
    • Schott AG (Carl-Zeiss-Stiftung)
    • SHL Medical/Group
    • Stevanato Group
    • Vetter Pharma International GmbH
    • Weigao Group
    • West Pharmaceutical Services, Inc.
    • Ypsomed Holding AG

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]